SPP1 (secreted phosphoprotein 1), also known as osteopontin (OPN), was originally described in bone tissue [109]; however, its expression was also described in different cancers, including ovarian [110], as a protein involved in tumor progression, metastasis, and drug resistance [111]. Here, SPP1 is linked to cancer.